Connect with us

Technology

Biologit Boosts Patient Safety with World-First Automated Local Literature Monitoring Solution for Non-Indexed Sources

Published

on

* Biologit for Local Literature™ delivers results 15 x faster than traditional searches, and is considerably more accurate and reliable. * The new managed service, already live at a top 10 pharma company, harnesses a technology ingestion model built by Biologit to fill a critical gap in pharmacovigilance, at scale. *Local literature surveillance is a highly resource-intensive mandatory activity, with significant budget implications yet with relative low yield for safety events.

DUBLIN, April 2, 2025 /PRNewswire-PRWeb/ — Biologit, a specialist in advanced, technology-enabled safety surveillance solutions for life sciences, has launched a world-first automation solution for local literature monitoring. Biologit for Local Literature™ solves the costly and complex problem of how to reliably identify adverse events and relevant safety information across the full spectrum of local literature sources, including non-indexed and hard-to-access country-specific publications.

This is a huge breakthrough for pharmacovigilance and patient safety. Truly comprehensive local literature screening has been a huge headache – and cost – for the pharma industry up to now.

The new managed data service, which is already live at a top 10 global biopharma company, fills a critical gap in current international safety surveillance. That’s because a significant proportion of adverse events first come to light via discrete local medical publications and online sources that are not picked up by routine open-source global literature searches. The activity’s critical importance is recognised by regulators, which mandate that pharma companies screen for safety events in all relevant markets.

The traditional screening process for local medical literature is inefficient and unreliable:

Highly manual and time-consuming, it requires dedicated staff at an affiliate or regional level;It yields only limited safety information. Errors and omissions are common;These issues are compounded by inconsistency in the format, indexing; access issues (e.g. paid subscriptions/print-only formats); language barriers; and variances in regulators’ reporting expectations.

Biologit for Local Literature uses advanced technology to overcome this challenge, efficiently, reliably and at scale. It has been shown to yield a 15-fold acceleration in safety event reporting when applied to a broad spectrum of local sources across 30 EU countries, with impressive accuracy.

Optimised algorithms, closely governed

Biologit for Local Literature uses a technology-based ingestion model developed by Biologit’s expert engineers. Each source is evaluated, and proprietary technology methods (including optimised algorithms that act as automated ‘crawlers’ per site) are used to support the ingest of any non-indexed in-country literature source as required. Even hard-to-reach print sources, conference proceedings and websites are included. As part of the managed service, Biologit’s operations team then confirms the findings manually, balancing process innovation with strong governance to contain any risk and ensure the product is audit-ready.

This innovative solution complements the company’s existing Biologit Database™, an extensive and continuously updated range of indexed, open-source global, regional and national medical publications and online resources. The ability to screen more diverse, non-standardised local sources in a reliable and highly efficient way – and filter searches by country – via Biologit’s new bespoke managed data service, rounds off the solution suite.

The combined 360-degree screening is powered by Biologit Platform™, Biologit’s powerful scientific literature monitoring platform, which features flexible workflow and unique AI productivity features. Biologit for Local Literature removes the final source of pain and risk from literature monitoring, raising the overall benefit to patient safety. ALL safety events are accessible via a single window, or query.

Delivered via the Biologit Platform, Biologit for Local Literature covers all countries and includes automated machine translation for hundreds of languages. The innovative technology allows for country-level data filtering for specific local searches, and individual country reporting and audit trails. It also supports single, integrated searches for global and local safety events.

Commenting on the significance of Biologit for Local Literature, Nicole Baker, Biologit’s CEO and co-founder, said:

“This is a huge breakthrough for pharmacovigilance and patient safety. Truly comprehensive local literature screening has been a huge headache – and cost – for the pharma industry up to now. Worse than that, it hasn’t delivered. This world-first, tech-enabled managed service ensures accurate and complete coverage for all journals, websites and subscription-based publications of interest in a country, delivered with unprecedented efficiency.

“Our use of automation allows us to do this at scale. This is not about assigning large service teams, or trying to track everything in spreadsheets. With Biologit for Local Literature we harness technology including specially-developed crawlers which are fast and reliable, and everything is properly overseen by our skilled people, to verify the accuracy and reliability of the output. Given the high sensitivity of patient safety, and the strict PV/Regulatory requirements, we have taken great pains to balance innovation and risk, and the results are exceeding all expectations.”

A new white paper, A World First: Integrated, Automated Global & Local Literature Monitoring for Pharmacovigilance is available for download on the Biologit website here. To arrange a 1:1 demonstration please email jean.redmond@biologit.com.

About Biologit

Biologit is an innovator in pharmacovigilance (PV), revolutionising the way that life science organisations handle literature review and monitoring, using cutting-edge automation technology wherever appropriate. Founded with a mission to enhance patient safety and operational efficiency, Biologit empowers pharmaceutical, biotech and PV service providers to simplify and streamline their processes. At the heart of Biologit’s Platform is its AI-powered literature automation tool, designed to transform manual and time-intensive tasks into seamless, efficient workflows. Biologit adheres to the highest industry standards, including ISO 27001 certification, GxP compliance, and alignment with FDA regulations.

PR Contact

Carina Birt, Sarum Life Sciences

carina@sarumlifesciences.com

+44 7970 006624

Media Contact

Jean Redmond, biologit, 44 00000000000, jean.redmond@biologit.com, https://www.biologit.com/

View original content:https://www.prweb.com/releases/biologit-boosts-patient-safety-with-world-first-automated-local-literature-monitoring-solution-for-non-indexed-sources-302417543.html

SOURCE biologit

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Real-World Study of Over 185,000 Users Finds Engagement with UpLife Digital Mental Health App Yields Significant Reductions in Depression and Anxiety

Published

on

By

Five-year evaluation shows a clear “dose–response” link between deeper engagement with UpLife’s CBT-based ‘Journeys’ programs and greater depression and anxiety symptom improvement

LEESBURG, Va., July 21, 2026 /PRNewswire-PRWeb/ — UpLife Inc, a digital mental health and self-therapy platform, today announced a set of research findings from a large real-world evaluation of its app, showing that people who engaged with the platform reported statistically significant reductions in symptoms of depression and anxiety over time. The evaluation drew on five years of real-world data from an engaged user base of more than 185,000 people across the United States and 197 other countries worldwide.

“These results reflect what we hear from users every day, now backed by data at real-world scale. What stands out is the dose–response signal where the people who lean into the work by completing their Journeys and doing the exercises are the ones who get the most out of it.” Jeff Musa, CEO, UpLife

The research analysis examined anonymized data collected between 2021 and 2026 using three validated clinical outcome measures: the PHQ-9 (depression), the GAD-7 (anxiety), and the WHO-5 (well-being). Among UpLife users who completed assessments at baseline and follow-up, depression and anxiety scores decreased significantly over time.

In the fully adjusted analysis, average depression scores (PHQ-9) fell by approximately 3.7 points; moving the typical UpLife user from the “moderately severe” range toward the “moderate” range. Anxiety scores (GAD-7) showed comparable significant reductions over time.

A clear dose–response relationship

One of the study’s central findings was a consistent dose–response pattern regarding the relationship between engagement and outcomes. Users who completed UpLife’s CBT-based ‘Journeys’ experienced a reduction in their symptoms. The study also found that the completion of additional Journeys were associated with a further measurable decrease in their assessment scores, even after accounting for subscription type and other factors. Notably, depth of engagement with therapeutic content was a stronger predictor of improvement than simply the amount of time spent in the app.

“These results reflect what we hear from users every day, now backed by data at real-world scale. What stands out most is the dose–response signal where the people who lean into the work by completing their Journeys and doing the exercises are the ones who get the most out of it. That tells us our job is to keep building an experience that helps people stay engaged, because engagement is where the clinical value lives.” — Jeff Musa, Chief Executive Officer, UpLife

Built on cognitive behavioral therapy

UpLife delivers evidence-based psychological education and interventions grounded in the principles of cognitive behavioral therapy (CBT) through five core features: structured Journeys, a Daily Plan, a Mood Tracker, journaling, and an AI assistant (“Lila”) that recommends relevant content from the platform. The app does not provide AI-generated therapy; its assistant only directs users to content that has been created, curated, and reviewed by clinicians.

For clinicians, UpLife also offers a HIPAA-compliant therapist portal that supports a Blended Care model, allowing providers to extend therapeutic support between sessions through structured digital programs, progress tracking, and shared assessments.

The platform has also been extensively used in humanitarian settings. Through UpLife’s Ukraine Humanitarian Gift Program, tens of thousands of users in Ukraine have received full, free access to a localized version of the app through UpLife’s Ukraine Humanitarian Gift Program.

About the evaluation

The study used an observational pre–post design based on real-world data and was conducted in accordance with the ethical principles of the Declaration of Helsinki. As an observational evaluation without a control group, it demonstrates associations between app engagement and symptom improvement rather than establishing causation, and well-being scores (WHO-5) did not change significantly over the study period. The findings add to a growing body of research suggesting that CBT-based digital interventions can be associated with meaningful symptom reduction, while underscoring the central role of sustained user engagement.

About UpLife

Founded in 2019, UpLife is a digital mental health and self-guided therapy platform that is designed to help people improve their emotional well-being, build healthier thinking patterns, and develop positive daily habits through structured, evidence-based psychological programs. UpLife also provides a secure, HIPAA-compliant portal to help therapists and health systems to extend care beyond the through a Blended Care Therapy model. Learn more at www.uplifecare.com.

Media Contact

Matt Landry, UpLife, 1 617-699-7205, matt@thesecondrow.net, https://www.uplifecare.com/ 

View original content:https://www.prweb.com/releases/real-world-study-of-over-185-000-users-finds-engagement-with-uplife-digital-mental-health-app-yields-significant-reductions-in-depression-and-anxiety-302829280.html

SOURCE UpLife

Continue Reading

Technology

TruHeight Joins Nordstrom and JCPenney Marketplaces as Wellness Brands Reshape the Department Store

Published

on

By

Family nutrition brand’s newest retail partnerships reflect a broader shift: health and wellness products are becoming a staple of platforms once reserved for fashion and apparel

LAS VEGAS, July 21, 2026 /PRNewswire/ — TruHeight, the family nutrition brand, today announced it is joining the Nordstrom Marketplace and the JCPenney Marketplace, bringing its lineup of clean-label vitamins, gummies, protein shakes, and everyday nutrition products to two of America’s most iconic department store names.

The partnerships place TruHeight at the center of one of retail’s most notable shifts. Department stores and fashion-first marketplaces, long defined by clothing, shoes, and accessories, are rapidly expanding into health and wellness as consumers increasingly treat wellness as part of their everyday lifestyle rather than a separate shopping trip. For a generation of shoppers, the same platforms where they buy back-to-school outfits and activewear are becoming destinations for the products that fuel those activities.

“Five years ago, you wouldn’t expect to find a family nutrition brand next to denim and sneakers,” said Justin Rapoport, Co-CEO of TruHeight. “Today, wellness is part of how families shop for everything. Nordstrom and JCPenney recognize that, and we’re proud to bring family nutrition to their marketplaces.”

The move extends a period of rapid retail growth for TruHeight, which launched in 5,000 CVS stores nationwide in June following its national debut at Target earlier this year, and is also available at iHerb and on Amazon. With the addition of Nordstrom and JCPenney, TruHeight’s products will reach shoppers across drug, mass, e-commerce, and department store channels.

“Every retailer we add is a signal of the trust families place in our brand,” said Eden Stelmach, Co-Founder of TruHeight. “Department stores are where families have shopped together for generations. Meeting them there with simple, clean nutrition products is a natural next step.”

TruHeight products will be available on the Nordstrom and JCPenney marketplaces in the coming weeks, joining the brand’s existing availability at CVS, Target, iHerb, Amazon, and truheightvitamins.com.

About TruHeight
TruHeight is a family nutrition brand offering clean-label vitamins, gummies, protein shakes, and everyday nutrition products for kids, teens, and active families. Founded with a commitment to simple ingredients and convenient formats, TruHeight products are available at major retailers nationwide and online at truheightvitamins.com.

Media Contact
TruHeight Vitamins
Kim Brown
419189@email4pr.com
4704265920
truheightvitamins.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/truheight-joins-nordstrom-and-jcpenney-marketplaces-as-wellness-brands-reshape-the-department-store-302830436.html

SOURCE TruHeight Vitamins

Continue Reading

Technology

TrendyMinds Founder Trevor Yager Returns as CEO to Lead Agency’s Next Phase of Growth

Published

on

By

Veteran agency leader returns to accelerate TrendyMinds’ AI capabilities and advance the firm’s evolution as a strategic partner helping organizations drive growth, strengthen reputation, and navigate transformation.

INDIANAPOLIS, July 21, 2026 /PRNewswire/ — Trevor Yager has returned as Chief Executive Officer (CEO) of TrendyMinds, the Indianapolis-based agency he founded in 1995, while continuing to serve as Chairman. In this dual role, Yager has resumed direct involvement in day-to-day leadership, working alongside account and delivery teams on client work in addition to setting the agency’s strategic direction. As CEO, he is leading the company’s next phase of growth by advancing the firm’s artificial intelligence (AI) capabilities while strengthening its position as a strategic partner to organizations navigating growth and change.

Yager previously transitioned from CEO to Chairman as part of a planned leadership evolution that reflected both the agency’s maturity and his own exploration of future ownership opportunities. As AI has accelerated the pace of change across the industry, reshaping how organizations operate and compete, he made the decision to step back into the CEO role and lead TrendyMinds through its next chapter directly.

“Moving into the Chairman role was the right decision at the time because the Board, including myself, believed TrendyMinds needed to demonstrate it could thrive beyond its founder,” said Yager. “But after more than 30 years of leading through every major technology shift, I believe artificial intelligence represents one of the greatest opportunities our industry has ever seen. The environment shifted fast enough that it made sense for me to step back in and lead it personally, continuing to build the capabilities our clients will need and position the agency for what’s next.”

Beginning in 2019, TrendyMinds became increasingly intentional about optimizing the artificial intelligence, machine learning, and automation capabilities already embedded within the technologies used across the agency. Following a comprehensive assessment of AI-enabled tools and workflows, the agency integrated AI across strategy, research, creative development, marketing operations, and internal business processes while establishing governance, security, and data protection standards to support responsible implementation.

By transforming its own business first, TrendyMinds refined its methodologies, validated new approaches, and built the operational discipline that now informs how it evaluates AI opportunities with clients. Today, TrendyMinds continues to expand its internal AI capabilities through a dedicated team of AI transformation specialists, developing proprietary workflows, audience intelligence tools, and implementation frameworks. Drawing on that experience, the agency helps clients responsibly evaluate and implement AI in ways that align with their business objectives, regulatory requirements, and governance standards.

That experience also enables TrendyMinds to support clients developing innovative AI technologies, including a leading healthcare AI innovator. By combining firsthand AI transformation experience with strategic consulting, communications, and market positioning expertise, the agency helps organizations communicate complex technologies, build trust with stakeholders, and accelerate market adoption.

Founded as a traditional marketing agency more than 30 years ago, TrendyMinds has continually evolved alongside the changing needs of its clients, bringing together strategic consulting, integrated marketing, communications, creative, thought leadership, media relations, digital strategy and development, research, analytics, and emerging technologies.

About TrendyMinds

TrendyMinds is the Agency of Preference®, a multidisciplinary consulting partner helping organizations accelerate growth, strengthen and protect reputation, and navigate transformation. Founded in Indianapolis in 1995, the firm has spent more than 30 years uniting strategic consulting, communications, marketing, creative, technology, and data-driven insight into a single integrated practice built to solve complex business challenges.

Learn more at TrendyMinds.com.

Media Contact:
Claire Gregory
419095@email4pr.com | 317.902.6973

View original content to download multimedia:https://www.prnewswire.com/news-releases/trendyminds-founder-trevor-yager-returns-as-ceo-to-lead-agencys-next-phase-of-growth-302830444.html

SOURCE TrendyMinds

Continue Reading

Trending